Navigation Links
Pro-Dex, Inc. Announces Fiscal 2011 Fourth Quarter and Full-Year Financial Results Conference Call and Webcast
Date:9/8/2011

IRVINE, Calif., Sept. 8, 2011 /PRNewswire/ -- PRO-DEX, INC. (Nasdaq: PDEX) invites investors and analysts to listen to a broadcast review of the Company's fiscal 2011 fourth quarter and full-year financial results.

The conference call is scheduled to be broadcast live over the internet on Wednesday, September 14, 2011 at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) and may be accessed by visiting the Company's website at www.pro-dex.com and selecting the "Investor Relations" page. The conference call may also be accessed at www.InvestorCalendar.com. Investors and analysts who would like to participate in the conference call may do so via telephone at (877) 407-8033, or at (201) 689-8033 if calling from outside the U.S.

For those who cannot access the live broadcast, a replay will be available from approximately two hours after the completion of the call until midnight (Eastern Time) on September 28, 2011 by calling (877) 660-6853, or (201) 612-7415 if calling from outside the U.S., and then entering account number 286 and conference I.D. number 378851. An online archive of the broadcast will be available on the Company's website at www.pro-dex.com, on the "Investor Relations" page, for a period of 365 days.

Pro-Dex, Inc., with operations in California, Oregon and Nevada, specializes in bringing speed to market in the development and manufacture of technology-based solutions that incorporate powered surgical device drive systems, embedded motion control and fractional horsepower DC motors, serving the medical, dental, semi-conductor, scientific research and aerospace markets. Pro-Dex's products are found in hospitals, dental offices, medical engineering labs, commercial and military aircraft, scientific research facilities and high tech ma
'/>"/>

SOURCE Pro-Dex, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. PRO-DEX, INC. Announces Fiscal First Quarter 2010 Profit, Update on Business Development Activities, and Renewal of Banking Agreement
2. Pro-Dex, Inc. Announces Fiscal Second Quarter 2010 Results
3. Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customers Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders
4. Pro-Dex, Inc. Announces Fiscal 2010 Third Quarter Financial Results Conference Call and Webcast
5. Pro-Dex, Inc. Appoints Harold A. Hurwitz as Chief Financial Officer
6. Pro-Dex, Inc. Announces Fiscal Second Quarter and Six Month Results
7. Pro-Dex, Inc. Announces Fiscal 2011 Third Quarter Financial Results Conference Call and Webcast
8. Pro-Dex, Inc. Announces Fiscal Third Quarter and Nine Month Results
9. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
10. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
11. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... SAN DIEGO , July 24, 2014 /PRNewswire/ ... an innovative new direct-to-consumer prescription delivery channel in ... many of the underlying issues related to medication ... study published in a recent issue of the ... In the study, researchers reported that frequent changes ...
(Date:7/24/2014)... and VANCOUVER, British Columbia , ... OGXI ) announced today that the Company,s ... Thursday, August 7, 2014, and that the Company will ... p.m. ET that afternoon. Management will provide an overview ... general business update. To access the ...
(Date:7/23/2014)... PALO ALTO, Calif., July 23, 2014  Varian Medical ... net earnings of $1.02 per diluted share in the ... negatively impacted by about $0.06 per diluted share due ... a portion of Varian,s existing equity investment in Augmenix, ... Varian,s company-wide revenues totaled $748 million for the third ...
Breaking Medicine Technology:Medication Non-Adherence Issue Highlighted in Annals of Internal Medicine Study Could Be Eliminated by a New Direct-to-Consumer Delivery Channel Ensuring Consistent Medication Appearance 2Medication Non-Adherence Issue Highlighted in Annals of Internal Medicine Study Could Be Eliminated by a New Direct-to-Consumer Delivery Channel Ensuring Consistent Medication Appearance 3OncoGenex to Report Financial Results for Second Quarter 2014 on August 7, 2014 2Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 2Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 3Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 4Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 5Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 6Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 7Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 8Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 9Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2014 10
... Challenges Explorations to support bold, ... diseases, SEATTLE, March 3 The Bill & Melinda ... accept grant,proposals for the first funding round of Grand Challenges ... globe pursue,ideas that have never before been tested for solving ...
... Research Management,Organization (RMO), has contracted with Systems Medicine ... (CTI), to provide,research and site management services for ... myxoid liposarcoma with a (12;16),translocation. The study is ... experimental drug product, brostallicin. The trial will also ...
Cached Medicine Technology:Gates Foundation Seeks Proposals for Innovative Global Health Research 2Gates Foundation Seeks Proposals for Innovative Global Health Research 3Pharmatech Teams up With Systems Medicine LLC and the Sarcoma Foundation of America for a Phase II Myxoid Liposarcoma Trial 2Pharmatech Teams up With Systems Medicine LLC and the Sarcoma Foundation of America for a Phase II Myxoid Liposarcoma Trial 3
(Date:7/24/2014)... July 24, 2014 The South American air ... million in 2014 and is expected to register a CAGR ... spends mainly on tackling internal security issues like drug trafficking. ... 75% share in the air and missile defense radar market. ... promising future in the market for radar systems in terms ...
(Date:7/24/2014)... The National Resident Matching Program (NRMP) ... new version of its smartphone app, The MATCH Program ... participating in NRMP’s Main Residency Match® and Specialties Matching ... program information during the interview process and develop program ... order lists. Rank order lists are used by ...
(Date:7/24/2014)... Indianapolis* VxP Pharma Services announced today ... include process development and commercial manufacturing for ... offered by VxP now include:, ...     Sterile Liquids and Sterile Powders , ...     Transdermal Patches ,     Animal Health ...
(Date:7/24/2014)... July 24, 2014 Becker's Hospital Review ... Hospitals and Health Systems With Great Oncology Programs." Organizations ... terms of quality patient care, cancer outcomes and research. ... for inclusion based on rankings and awards they have ... awards were considered as part of the criteria for ...
(Date:7/24/2014)... Dr. Kwame Bawuah Edusei, a diplomat, entrepreneur, medical ... to the youth to persevere in their endeavors to ... the youth to stay away from social vices and ... will afford you the opportunity of acquiring life surviving ... in your career path.” Professionals in the fields of ...
Breaking Medicine News(10 mins):Health News:South America Air and Missile Defense Radar Market is Expected to Reach $340 Million in 2020 - New Report by MicroMarket Monitor 2Health News:South America Air and Missile Defense Radar Market is Expected to Reach $340 Million in 2020 - New Report by MicroMarket Monitor 3Health News:South America Air and Missile Defense Radar Market is Expected to Reach $340 Million in 2020 - New Report by MicroMarket Monitor 4Health News:South America Air and Missile Defense Radar Market is Expected to Reach $340 Million in 2020 - New Report by MicroMarket Monitor 5Health News:National Resident Matching Program® (NRMP®) Releases New, Enhanced Version of its Smartphone App 2Health News:National Resident Matching Program® (NRMP®) Releases New, Enhanced Version of its Smartphone App 3Health News:VxP Pharma Expands Commercial Service Offering 2Health News:100 Hospitals, Health Systems With Great Oncology Programs 2Health News:100 Hospitals, Health Systems With Great Oncology Programs 3Health News:100 Hospitals, Health Systems With Great Oncology Programs 4Health News:Youth and Professionals Interact at Washington Metro Area Career Workshop Hosted by the Edusei Foundation 2
... critical levels compelled the Iranian Government to declare two ... country will remain closed on// 7 and 8 December ... Tehran have already been closed down by the Government, ... problems have been advised to remain indoors. ...
... persistent pain may be increased by an inflamed injury, according ... even after it has disappeared//. Several million Canadians are reported ... has published the study. The NR2B proteins in mice are ... to imprint upon the brain a painful response even when ...
... treatment can be given to eligible patients inclusive ... stage III colon cancer, according to the Journal ... study. The survival rates are reportedly higher with ... received chemotherapy after surgery to treat their advanced ...
... of the deadly bird flu, official reports from China has ... to be infected with the disease//. The victim hails from ... and pneumonia since November 23. ,A test done ... H5N1 infection and has a positive history of exposure to ...
... Two Chinese manufacturers who were making and selling inferior ... of several children after being fed with this fake ... estimates, up to 200 babies after being fed the ... doctors diagnosed the condition as "big head disease", where ...
... mechanism by which Hepatitis C could cause liver cancers is ... from the University of Texas have now discovered a biochemical ... between liver cancer and Hepatitis C. The link or association ... human papilloma virus (HPV), cervical cancer and genital warts. ...
Cached Medicine News:Health News:Chemotherapy Treatment Can Be Given To The Elderly also 2Health News:Bird Flu Infection Of Chinese Girl Prompts Fear Of Spread Across Asia 2Health News:Link Between Hepatitis C And Liver Cancer Unraveled By Scientists 2
Full Handle Laseredge Implant Blade Knife, 5.2 mm angled bevel up. Blade dimension: 16.5 mm x 5.2 mm x 4.2 mm x 1.6 mm....
Full Handle Laseredge Implant Blade Knife, 4.0 mm angled bevel up. Blade dimension: 15.2 mm x 4.0 mm x 3.0 mm x 1.6 mm....
Full Handle Laseredge Crescent Blade Knife, angled bevel down. Blade tip dimension: 12.7 mm x 2.0 mm x 3.8 mm....
Full Handle Laseredge Crescent Blade Knife, straight. Blade tip dimension: 12.7 mm x 2.0 mm x 3.8 mm....
Medicine Products: